cheap glp 1 medication GLP-1 weight loss drugs to become cheaper for some under temporary Medicare program 1 medications or looking to feel their best every day. Federal deal could make popular

Furthermore, GLP-1 RAs are not recommended for patients with severe gastrointestinal diseases (e.g., gastroparesis and inflammatory bowel disease)

Additionally, GLP-1 RAs should be considered in overweight or obese patients to reduce weight (class IIa, level B)

Ideally, these medications should be started when Crohn's disease is in remission, with close collaboration between your gastroenterology and diabetes/obesity teams

The trial results show significant reductions in both blood sugar (A1C levels) and body weight among adults with type 2 diabetes, setting the stage for a potential new alternative to injectable therapies